EG20114A - Process for preparing of improved lyophilized ifosfamide compositions - Google Patents

Process for preparing of improved lyophilized ifosfamide compositions

Info

Publication number
EG20114A
EG20114A EG63992A EG63992A EG20114A EG 20114 A EG20114 A EG 20114A EG 63992 A EG63992 A EG 63992A EG 63992 A EG63992 A EG 63992A EG 20114 A EG20114 A EG 20114A
Authority
EG
Egypt
Prior art keywords
preparing
ifosfamide compositions
improved
improved lyophilized
lyophilized ifosfamide
Prior art date
Application number
EG63992A
Other languages
English (en)
Inventor
Lee Alexander Robert
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of EG20114A publication Critical patent/EG20114A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
EG63992A 1991-10-23 1992-10-21 Process for preparing of improved lyophilized ifosfamide compositions EG20114A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/781,436 US5227373A (en) 1991-10-23 1991-10-23 Lyophilized ifosfamide compositions

Publications (1)

Publication Number Publication Date
EG20114A true EG20114A (en) 1997-07-31

Family

ID=25122737

Family Applications (1)

Application Number Title Priority Date Filing Date
EG63992A EG20114A (en) 1991-10-23 1992-10-21 Process for preparing of improved lyophilized ifosfamide compositions

Country Status (24)

Country Link
US (1) US5227373A (de)
EP (1) EP0538858B1 (de)
JP (1) JP3576180B2 (de)
KR (1) KR100247161B1 (de)
CN (1) CN1046202C (de)
AT (1) ATE175354T1 (de)
AU (1) AU658011B2 (de)
CA (1) CA2081061A1 (de)
CZ (1) CZ282445B6 (de)
DE (1) DE69228105T2 (de)
DK (1) DK0538858T3 (de)
EG (1) EG20114A (de)
ES (1) ES2125880T3 (de)
FI (1) FI107701B (de)
GR (1) GR3029835T3 (de)
HU (2) HU221428B (de)
IL (1) IL103496A (de)
MX (1) MX9206105A (de)
MY (1) MY109794A (de)
NZ (1) NZ244816A (de)
RU (1) RU2106138C1 (de)
SK (1) SK279869B6 (de)
TW (1) TW217987B (de)
ZA (1) ZA928104B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
US5789000A (en) * 1994-11-14 1998-08-04 Bionumerik Pharmaceuticals, Inc. Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
DE59813853D1 (de) * 1997-10-13 2007-02-01 Stada Arzneimittel Ag Flüssige darreichungsformen oxazaphosphorinhaltiger pharmazeutischer produkte
US5972912A (en) * 1998-12-17 1999-10-26 S.P. Pharmaceuticals Method for lyophilizing ifosfamide
US6613927B1 (en) 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
AR038535A1 (es) * 2002-02-22 2005-01-19 Schering Corp Formulaciones farmaceuticas de agentes antineoplasicos y procesos para prepararlos y usarlos
US20050272698A1 (en) * 2002-09-05 2005-12-08 Daftary Gautam V Liquid stable composition of oxazaphosphorine with mesna
US7199111B2 (en) * 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations
CN100463678C (zh) * 2002-12-02 2009-02-25 印度血清及疫苗有限公司 用于肠胃外给药的异环磷酰胺组合物及其制备方法
CA2540537A1 (en) * 2003-10-01 2005-04-14 Baxter International Inc. New use, pharmaceutical preparations as well as a process for their production
MX2007005361A (es) * 2004-11-05 2008-01-11 Cephalon Inc Tratamientos para cancer.
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
NZ575936A (en) * 2006-09-29 2011-11-25 Infa Sa Packaging system for pharmaceutical compositions and kit for intravenous administration
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
TW200845962A (en) * 2007-05-08 2008-12-01 Schering Corp Methods of treatment using intravenous formulations comprising temozolomide
AR072777A1 (es) * 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
EP2889029A1 (de) 2008-09-25 2015-07-01 Cephalon, Inc. Flüssige Formulierungen aus Bendamustin
BRPI1004922A2 (pt) * 2009-01-15 2019-09-24 Cephalon Inc composição farmacêutica, forma cristalina da base livre de bendamustina e método de tratamento de leucemia linfocítica crônica, doença de hodgkin, linfoma não-hodgkin, mieloma múltiplo ou câncer da mama
EP2410996B1 (de) 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Impfstoffe in mikropartikelform zur oralen oder nasalen impfung und stärkung von tieren einschliesslich fischen
NZ597053A (en) * 2009-05-26 2014-02-28 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
LT2603100T (lt) 2010-08-13 2018-07-25 Advanced Bionutrition Corp. Stabilizuojanti kompozicija, skirta biologinių medžiagų sausam saugojimui
US20160324809A1 (en) 2014-01-06 2016-11-10 Auxin Surgery Sa Lyophilized mesna compositions
US10342769B2 (en) 2014-11-14 2019-07-09 Navinta Iii Inc Carmustine pharmaceutical composition
CA2994112C (en) 2015-07-29 2023-08-08 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
JP6706988B2 (ja) * 2016-07-20 2020-06-10 日本化薬株式会社 ボルテゾミブを含有する医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
EP0254902B1 (de) * 1986-07-11 1991-08-28 ASTA Pharma Aktiengesellschaft Lösungen von Oxazaphosphorinen mit verbesserter Stabilität und Verfahren zu deren Herstellung
NO873860L (no) * 1986-10-31 1988-05-02 Asta Pharma Ag Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.
ATE63121T1 (de) * 1987-03-06 1991-05-15 Asta Pharma Ag Verfahren zur herstellung von ifosfamid mit verbesserten eigenschaften.
ES2040394T3 (es) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft Procedimiento para preparar un material liofilizado de ifosfamida y mesna.
US5036060A (en) * 1988-07-25 1991-07-30 Fujisawa Usa, Inc. Cyclophosphamide

Also Published As

Publication number Publication date
RU2106138C1 (ru) 1998-03-10
NZ244816A (en) 1994-06-27
CN1046202C (zh) 1999-11-10
DE69228105T2 (de) 1999-08-26
AU658011B2 (en) 1995-03-30
IL103496A0 (en) 1993-03-15
TW217987B (de) 1993-12-21
CZ317692A3 (en) 1993-09-15
US5227373A (en) 1993-07-13
IL103496A (en) 1996-07-23
FI924797A0 (fi) 1992-10-22
HU211293A9 (en) 1995-11-28
MY109794A (en) 1997-06-30
SK279869B6 (sk) 1999-04-13
FI924797A (fi) 1993-04-24
ATE175354T1 (de) 1999-01-15
CA2081061A1 (en) 1993-04-24
CN1073358A (zh) 1993-06-23
ES2125880T3 (es) 1999-03-16
MX9206105A (es) 1993-04-01
DE69228105D1 (de) 1999-02-18
AU2716692A (en) 1993-04-29
HUT69384A (en) 1995-09-28
KR100247161B1 (ko) 2000-04-01
KR930007453A (ko) 1993-05-20
GR3029835T3 (en) 1999-06-30
EP0538858B1 (de) 1999-01-07
JP3576180B2 (ja) 2004-10-13
FI107701B (fi) 2001-09-28
HU221428B (en) 2002-10-28
CZ282445B6 (cs) 1997-07-16
HU9203306D0 (en) 1992-12-28
JPH05246856A (ja) 1993-09-24
ZA928104B (en) 1993-07-20
DK0538858T3 (da) 1999-08-30
EP0538858A1 (de) 1993-04-28
SK317692A3 (en) 1995-11-08

Similar Documents

Publication Publication Date Title
EG20114A (en) Process for preparing of improved lyophilized ifosfamide compositions
RU92004463A (ru) Усовершенствованные лиофилизированные поросерамидные композиции
EP0483329A4 (en) Novel lyophilized and reconstituted cell compositions
DK0490823T3 (de)
NO913885D0 (no) Fibere for spontan transport av fluider.
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
WO1998017319A3 (en) Platelet substitutes and conjugation methods suitable for their preparation
NO2004004I1 (no) Bortezomib eller en farmasøytisk akseptabel ester derav, eventuelt i form av et farmasøytisk akseptabelt salt derav
ES2055048T3 (es) Liofilizacion de eritrocitos y medios para usarse en ella.
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
PT94344A (pt) Processo para a preparacao de uma composicao estavel seca por congelacao a base de esteres/eteres de poli-hematoporfirina
HUT65418A (en) Process for producing inclusion compounds of nimesulide with cyclodextrins and pharmaceutical preparatives containing them
PT89289A (pt) Processo para a preparacao de uma composicao de protoplastos estabilizados
IT8921488A0 (it) Apparecchiatura a letto fluidizzato circolante adatta per la gassificazione di una carica d'alimentazione carboniosa, in particolare carbone.
DE3884663D1 (de) Gefriergetrockneter, stabiler, lebendiger Herpesvirus-Impfstoff.
USD288356S (en) Airtight wood and coal box heater
USD300354S (en) Wood and coal burning stove
GR3002215T3 (en) Calcium lactate-glycerine additive, process for its preparation and its use
USD317521S (en) Supporting beam for conveyor elements or the like
USD266806S (en) Bed headboard or similar article
USD285269S (en) Furniture rail or similar article
MX9634A (es) Procedimiento para la preparacion de un activador plasminogeno hibrido, producto obtenido, mutante del mismo, vector hibrido para modificar adn y composicion farmaceutica que incluye el activador de plasminogeno.
IT1229323B (it) Procedimento per il confezionamento di prodotti suscettibili di assorbire anidride carbonica, in particolare per prodotti alimentari deperibili.
TH2729EX (th) ลูกล้อสำหรับเฟอร์นิเจอร์
IT8719056A0 (it) Confezione per prodotti deperibili col calore, particolarmente ma non esclusivamente prodotti alimentari surgelati.